SB 1653 would allow Oklahoma to join the Occupational Therapy Licensure Compact, enabling licensed occupational therapists and assistants from participating states to practice in Oklahoma without obtaining a separate Oklahoma license. This "Compact Privilege" applies when the patient is located in Oklahoma (the "Remote State"), preserving each state's regulatory authority while facilitating interstate practice. The bill establishes mutual recognition of licenses, supports military spouses relocating across states, and includes provisions for telehealth services and sharing disciplinary information between states. It directly affects occupational therapists seeking to practice across state lines and enhances access to services for patients in Oklahoma.
HB 2268 requires the Oklahoma Medicaid Program or its contracted entities to reimburse providers for "cognitive assessment and care planning services" (defined using standard medical billing code 99483). This directly affects low-income Medicaid beneficiaries who receive these specific cognitive care services. The bill mandates reimbursement for these services under existing Medicaid rules, with no new funding or eligibility changes. It takes effect November 1, 2025.
SB 1984 amends Oklahoma's Osteopathic Medicine Act to modernize regulations for osteopathic physicians and the State Board of Osteopathic Examiners. It clarifies definitions (like "emergency" and "emergency suspension"), expands the Board's subpoena power and authority to design exams, and updates disciplinary procedures by adding/removing grounds for action. The bill also requires electronic license renewals, clarifies telemedicine practice rules (requiring a proper patient record for remote care), and specifies conditions for emergency license suspensions. These changes directly affect licensed osteopathic physicians in Oklahoma, the regulatory Board, and patients through updated oversight and licensing processes.
SB 1567 modifies Oklahoma's rules for Advanced Practice Registered Nurses (APRNs) by allowing supervising physicians to charge reasonable fees for oversight services, requiring these fees to be disclosed in written agreements and based on fair market value. The bill prohibits the Oklahoma Board of Nursing from imposing fees for maintaining supervision agreements or related administrative tasks. It also mandates that supervision agreements include specific details like fee structures, scope of practice, emergency plans, and alternate physician designations. This directly affects APRNs who rely on physician supervision and supervising physicians, streamlining oversight requirements while ensuring transparency in fee arrangements.
SB 1428 creates the Office of Alzheimer’s Disease and Related Dementia Service Coordination within Oklahoma’s State Department of Health, effective November 1, 2026. The office will coordinate statewide dementia services, eliminate duplicated efforts, collect data, support staff training, and identify grant opportunities to improve care for individuals with Alzheimer’s or related dementias and their caregivers. It requires the office to maintain a full-time dementia services coordinator position to manage operations. The bill repeals two outdated sections of Oklahoma law (63 O.S. 2021, Sections 1-879.2 and 1-879.3) related to dementia services.
SB 1644 would require Oklahoma's health department to add alpha-gal syndrome (AGS) to the official list of reportable diseases, meaning doctors, nurses, and clinical laboratories must report diagnosed cases to the state health department. AGS is a condition causing allergic reactions to red meat and other animal products, which currently lacks formal tracking in Oklahoma. The bill updates existing health reporting laws to include AGS and makes the language gender-neutral. It would take effect on November 1, 2026.
HB 1168 makes it a felony to knowingly deliver or possess abortion-inducing drugs (like misoprostol or methotrexate) with the intent of causing an abortion, punishable by up to $100,000 in fines or 10 years in prison. It directly affects individuals who provide such drugs for non-exceptional purposes, including off-label use for abortion. Key exceptions include pharmacists, manufacturers, and distributors acting within lawful medical practices, as well as preventive contraception used as directed by manufacturers. The law does not restrict treatment for ectopic pregnancies, miscarriages, or medical uses of drugs like chemotherapy.
SB 1344 creates Oklahoma's Insulin Access and Affordability Program, administered by the State Department of Health, to increase access to affordable insulin for residents. The bill requires the Department to provide financial support to a nonprofit pharmaceutical manufacturer developing fast-acting biosimilar insulin, contingent on the manufacturer matching funds and agreeing to produce insulin at low cost without rebates (except as required by law). The agreement includes annual reporting on development progress and repayment terms if the insulin isn't produced and distributed as promised. This program directly affects Oklahoma residents needing insulin, public and private payors, and the specified nonprofit manufacturer.
SB 1134 allocates $100,000 from Oklahoma's General Revenue Fund to the Oklahoma Health Care Authority for the 2026 fiscal year. The bill directly provides funding for the Authority to carry out its legal duties. It declares an emergency to allow immediate implementation upon passage. This is a procedural appropriations measure with no policy changes beyond the specified funding amount.
SB 1142 allocates $100,000 from unallocated state funds to Oklahoma's Department of Mental Health and Substance Abuse Services for the 2025-2026 fiscal year. The funding is intended to support the department's existing duties, including providing mental health and substance abuse services to Oklahomans. The bill declares an emergency to allow immediate implementation upon approval, bypassing standard legislative timelines. This is a procedural funding measure, not a policy change, and remains pending before the Appropriations Committee.